Novartis is recalling some bottles of Excedrin, NoDoz,
Sunday over concerns that the bottles could contain stray pills.
(UPI) -- Novartis Consumer Health is recalling Excedrin, Bufferin, Gas-X
Prevention and NoDoz in the United States after reports of chipped and broken
pills.
Novartis also reported inconsistent bottle-packaging practices at the
company's Lincoln, Neb., facility, which could result in the bottles containing
foreign tablets, caplets or capsules, the U.S. Food and Drug Administration said
Monday.
"Mixing of different products in the same bottle could result in consumers
taking the incorrect product and receiving a higher or lower strength than
intended or receiving an unintended ingredient," the FDA said in a statement.
"This could potentially result in overdose, interaction with other medications a
consumer may be taking, or an allergic reaction if the consumer is allergic to
the unintended ingredient."
The voluntary recall includes all lots of select bottle-packaging
configurations from retailers of Excedrin and NoDoz products with expiration
dates of Dec. 20, 2014, or earlier, and Bufferin and Gax-X products with
expiration dates of Dec. 20, 2013, or earlier.
© YellowBrix, Inc. Copyright 2010
